Furthermore, GPER (over)expression has been associated with many cancers and in particular poor prognosis in a number of cancers, including breast [33], ovarian [34], lung [35], pancreatic [36], and endometrial [37] although observations to the contrary have also been reported [38, 39]. Here, GPER1 is linked to cancer.